Company / Return on Equity (ROE)
Biohaven Ltd. Return on Equity (ROE) History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-199.9%
FY2024
5-year range
-199.9% / -95.4%
FY2022-FY2024
Trend
-109.6%
vs FY2023
Sector context
#184 of 190
Health Care
What the data says
Biohaven Ltd. reports negative total equity of -199.9% in FY2024. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-199.9% in FY2024.
Declined from -105.8% to -199.9% over the past 2 years.
Health Care sector context is included.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 190This company -199.9% Sector average -50.4%
▼
-296.4% below sector average
Key checks
Key Insights
- In FY2024, return on equity (roe) decreased 109.6% year-over-year.
- Currently 149.5pp below the Health Care sector average.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -199.9% | -109.6% |
| FY2023 | -95.4% | +9.9% |
| FY2022 | -105.8% | - |
| FY2021 | - | - |
| FY2020 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026